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Effects of Regional Versus General Anesthesia on
Outcomes After Total Hip Arthroplasty
A Retrospective Propensity-Matched Cohort Study
Mohammad A. Helwani, MD, Michael S. Avidan, MBBCh, Arbi Ben Abdallah, PhD, Dagmar J. Kaiser, MD,
John C. Clohisy, MD, Bruce L. Hall, MD, and Heiko A. Kaiser, MD
Investigation performed at the Washington University in St. Louis School of Medicine, St. Louis, Missouri

Background: Many orthopaedic surgical procedures can be performed with either regional or general anesthesia. We
hypothesized that total hip arthroplasty with regional anesthesia is associated with less postoperative morbidity and
mortality than total hip arthroplasty with general anesthesia.
Methods: This retrospective propensity-matched cohort study utilizing the American College of Surgeons National Surgical
Quality Improvement Program (ACS NSQIP) database included patients who had undergone total hip arthroplasty from 2007
through 2011. After matching, logistic regression was used to determine the association between the type of anesthesia and
deep surgical site infections, hospital length of stay, thirty-day mortality, and cardiovascular and pulmonary complications.
Results: Of 12,929 surgical procedures, 5103 (39.5%) were performed with regional anesthesia. The adjusted odds for
deep surgical site infections were signiﬁcantly lower in the regional anesthesia group than in the general anesthesia group
(odds ratio [OR] = 0.38; 95% conﬁdence interval [CI] = 0.20 to 0.72; p < 0.01). The hospital length of stay (geometric mean)
was decreased by 5% (95% CI = 3% to 7%; p < 0.001) with regional anesthesia, which translates to 0.17 day for each total
hip arthroplasty. Regional anesthesia was also associated with a 27% decrease in the odds of prolonged hospitalization (OR =
0.73; 95% CI = 0.68 to 0.89; p < 0.001). The mortality rate was not signiﬁcantly lower with regional anesthesia (OR = 0.78;
95% CI = 0.43 to 1.42; p > 0.05). The adjusted odds for cardiovascular complications (OR = 0.61; 95% CI = 0.44 to 0.85) and
respiratory complications (OR = 0.51; 95% CI = 0.33 to 0.81) were all lower in the regional anesthesia group.
Conclusions: Compared with general anesthesia, regional anesthesia for total hip arthroplasty was associated with a
reduction in deep surgical site infection rates, hospital length of stay, and rates of postoperative cardiovascular and
pulmonary complications. These ﬁndings could have an important medical and economic impact on health-care practice.
Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

Peer Review: This article was reviewed by the Editor-in-Chief and one Deputy Editor, and it underwent blinded review by two or more outside experts. It was also reviewed
by an expert in methodology and statistics. The Deputy Editor reviewed each revision of the article, and it underwent a ﬁnal review by the Editor-in-Chief prior to publication.
Final corrections and clariﬁcations occurred during one or more exchanges between the author(s) and copyeditors.

T

otal hip arthroplasty is a common and effective treatment for end-stage hip osteoarthritis. More than 200,000
primary total hip replacements and 36,000 revisions are
performed each year in the United States1.

Complications following total hip arthroplasty are rare,
with the rate of any major thirty-day complication commonly
reported to be 0.2% to 1.2%. Studies have suggested that older
age and a worse American Society of Anesthesiologists (ASA)
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physical status classiﬁcation2 as well as cardiovascular disease,
pulmonary disease, and diabetes are associated with higher
risks of death and postoperative complications3-5. Total hip
arthroplasty is performed either with regional anesthesia,
typically spinal anesthesia, or with general anesthesia, depending on the discretion of the anesthesiology team, surgeon
preference, and patient choice. There is a lack of robust evidence regarding postoperative outcomes to inform the choice
of anesthetic technique. Regional anesthesia has been hypothesized to decrease postoperative complications by reducing sympathetic activation and inﬂammation, by preventing
venous stasis, and by avoiding tracheal intubation and positive
pressure ventilation6-8. However, to our knowledge, the inﬂuence of anesthesia type on clinical outcomes has not been
studied with large clinical trials, and the investigations that have
been done have produced conﬂicting results9-11. In 2006,
Mauermann et al. performed a meta-analysis of studies carried
out from 1966 to 2005 and found lower rates of deep vein
thrombosis and pulmonary embolism following total hip arthroplasties done with regional anesthesia compared with those
done with general anesthesia12. They found no difference in
transfusion requirements between the groups12, whereas other
studies showed blood transfusion requirements to be lower
with regional anesthesia13. Most of these positive studies were
conducted years ago and may not reﬂect current practice. Over
the last two decades, anesthesia care, surgical techniques, and
postoperative care have improved, resulting in decreased perioperative morbidity and mortality despite increasing patient
age and comorbidities14,15. While several recent studies utilizing
large databases have suggested that regional anesthesia is superior for hip fracture surgical procedures, we are aware of only
two studies of elective total hip arthroplasty that suggested that
regional anesthesia (spinal or epidural) might be associated
with lower rates of in-hospital complications and ninety-day
mortality5,16.
Minimizing complications of total hip arthroplasty is
an important public health concern. Despite the mounting
evidence that regional anesthesia might be associated with
improved outcomes, current American College of Surgeons
National Surgical Quality Improvement Program (ACS NSQIP)
data show that general anesthesia is still chosen for the majority
of total hip arthroplasties. We therefore conducted a propensitymatched analysis to test the hypothesis that use of regional anesthesia decreases deep surgical site infection rates, hospital
length of stay, postoperative mortality, and rates of cardiovascular and respiratory complications compared with general
anesthesia in patients treated with total hip arthroplasty.
Materials and Methods

T

he ACS NSQIP is conducted under institutional review board approval at
Barnes-Jewish Hospital, Washington University in St. Louis. The present study
was performed with use of the preexisting and deidentiﬁed Participant Use Data File
and thus was exempt from further review. The STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) checklist for observational studies
17
was used to guide the methods of this study and to structure this manuscript .
We conducted a retrospective cohort study with prospectively collected
data on adults undergoing elective total hip replacement from January 1, 2007,
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through December 31, 2011, who were part of the ACS NSQIP. The purpose of
the ACS NSQIP is to provide risk-adjusted clinical outcome data to participating hospitals to drive effective quality improvement. The database consists
of 135 perioperative variables and thirty-day postoperative morbidity and
mortality outcomes for patients treated with non-cardiac surgery.
Dedicated data personnel collect, validate, and submit the data at each site
after rigorous uniform training and examination. Per ACS NSQIP guidelines, all
variables, including complications, have predeﬁned deﬁnitions and speciﬁcations
(http://site.acsnsqip.org). During the submission of data from each institution,
user information prompts are implemented to ensure completeness, uniformity,
and validity of the data. Data integrity measures, including site visits, conference
calls, an annual meeting of participants, interrater reliability site visits, and auditing, are regularly performed to safeguard the reliability and validity of the
system’s data. Several studies have demonstrated the high quality and validity of
18
the ACS NSQIP database ; the combined results of audits revealed an overall
disagreement rate of approximately 1.8% for all variables.
At the end of the calendar year 2011, 316 hospitals were included in the data
set; 49% of them were classiﬁed as “academic/teaching” and 51%, as “non-teaching.”
There were three types of participation in this study period: classic, targeted, and
essential. Classic programs have the least missing data on baseline characteristics of
interest, so they were included for the analysis in this study (see details below).

Inclusion and Exclusion Criteria
We queried the ACS NSQIP database using Current Procedural Terminology
(CPT) codes for primary total hip replacement (CPT 27130) and conversions to
or revisions of total hip arthroplasties (CPT 27132, 27134, 27137, and 27138).
All patients who received any regional anesthesia (spinal or epidural) or general
anesthesia for primary or revision total hip arthroplasty in the classic programs
were included. Demographic data, comorbidities, medical history, and surgical
characteristics, including the type of procedure performed, were obtained for
all identiﬁed patients. Case exclusion criteria were cases from non-classic
programs as those programs had not collected data on ten of the thirty-two
baseline variables, an age under sixteen years, preoperative mechanical ventilation as regional anesthesia is not an option when mechanical ventilation is
used, preoperative coma, and no report of the type of anesthesia or use of a type
other than spinal, epidural, or general anesthesia (Fig. 1).

Outcomes and Interpretation
Outcomes of interest were deep surgical site infection within thirty days after surgery
and hospital length of stay from the day of the surgery until discharge. Hospital
length of stay was used as a continuous variable, and it was also used as a categorical
variable—i.e., prolonged hospital length of stay (yes or no), deﬁned as longer than
the average plus two standard deviations (SD) of the mean. Furthermore, the
mortality rate as well as the rates of cardiovascular and pulmonary complications
within thirty days after surgery were assessed. Cardiovascular complications and
pulmonary complications were composite outcomes of other ACS NSQIP-deﬁned
events. A cardiovascular complication was deﬁned as the occurrence of myocardial
infarction, stroke, deep venous thrombosis, or pulmonary embolism. A pulmonary
complication was deﬁned as the occurrence of pneumonia or respiratory failure
requiring intubation as speciﬁed within ACS NSQIP.

Statistical Analysis
Demographic and clinical characteristics were compared between the regional
and general anesthesia groups by using Pearson chi-square tests for all
categorical variables. Possible selection bias was addressed by performing
propensity score matching. The propensity score for each individual is deﬁned
as the probability of receiving the treatment (regional anesthesia) given the
patient’s baseline characteristics and comorbidities (Table I). This incorporated
thirty-two variables, including demographic variables and comorbidities (some
of the thirty-two variables were combined to obtain a total of twenty-ﬁve
baseline variables used for matching).
Multiple matching models with different matching ratios and calipers
were evaluated to select a matching model with the overall best balance and the
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Fig. 1

Schematic demonstration of study sample. ACS NSQIP = American College of Surgeons National Surgical Quality Improvement Program, CPT = Current
Procedural Terminology, and THA = total hip arthroplasty.
smallest reduction in the number of treated patients (regional anesthesia
group). Nearest-neighbor matching with replacement with up to two controls
(general anesthesia group) for each treated patient (regional anesthesia group)
was used with a caliper of 0.05 SD of a patient’s predicted propensity score.
Nearest-neighbor matching selects, for each treated individual i, the control
individual with the smallest distance in propensity score from individual i. To
account for the fact that some treated cases could be matched to only one
control or one control could be used multiple times, weights were generated to
correct for this disproportion. Every treated patient received a weight of one,
and the weights for the matched control units were calculated by ntreatedi/
ncontroli, where ntreatedi and ncontroli were the number of treated and control units
in stratum i. The control group weights were then scaled to sum to the number
of uniquely matched control units. Following propensity score matching, the
balance of the matched treated and control groups was evaluated by calculating
variance ratios and absolute values of the standardized differences in means as
well as by performing the Hotelling test, which is a generalization of the Student
19-21
t statistic used in multivariate hypothesis testing
.
Unadjusted analyses were conducted for all outcomes before and after
propensity score matching. To depict the inﬂuence of propensity score matching
on the differences in outcomes, the t test and chi-square test were used before
matching; the weighted t test and chi-square test were used after matching as
deemed appropriate. Hospital length of stay was analyzed as a continuous outcome and as a binary outcome as prolonged hospital length of stay (a stay longer
than the geometric mean 1 [2 · SD]). Because hospital length of stay was not
normally distributed but rather was skewed to the right, a lognormal transformation was conducted to create a more normal distribution. Geometric means
with standard deviations were calculated for both groups. Comparisons were
conducted by using a weighted t test on the lognormal transformed length of stay,
22,23
and the geometric mean ratio was examined as an effect size estimate . Prolonged hospital length of stay was analyzed by performing a chi-square test before
matching and a weighted chi-square test after matching.
To further evaluate the potential effects of anesthesia type on outcome
variables, multivariable analyses were conducted after propensity matching to

adjust for speciﬁc covariates. Those covariates were deﬁned a priori on the basis
3,24
of clinical relevance reported in previous studies . The number of covariates
per logistic regression model was restricted to at least ten events per covariate to
decrease the likelihood of overﬁtting.
As an age of greater than ninety years was not reported as a continuous
variable in the ACS NSQIP data, we categorized age into three groups with
comparable sizes.
Conditional multivariable logistic regression was used to evaluate the
association between the type of anesthesia and deep surgical site infection,
thirty-day mortality, and cardiovascular and pulmonary complications by using
data from the matched patient cohort. A proportional hazard Cox regression
analysis was performed to determine whether regional or general anesthesia
had a signiﬁcant inﬂuence on hospital length of stay.
Goodness of ﬁt for the logistic regression was assessed with the log
likelihood ratio and the Wald and Hosmer-Lemeshow tests. For the proportional hazards Cox regression, we checked the proportionality of hazards by
testing for non-zero slopes in a generalized linear regression of the scaled
Schoenfeld residuals on functions of time, and additionally graphically by eye. A
p value of <0.05 was considered signiﬁcant in all applied tests. As the type of
procedure (that is, primary or revision) may affect the anesthesia type selection,
an interaction term was included in the regression models but was removed
later as it was not signiﬁcant. SPSS software (version 21; IBM, Armonk, New
York) was used for data handling, and R (version 2.15.3; Institute of Statistics
and Mathematics, R Foundation of Statistical Computing) with the packages
25,26
MatchIt and Survey was used for statistical analyses
.

Source of Funding
There was no external funding source for this study.

Results
rom 2007 to 2011, 20,606 total hip arthroplasties were included in the NSQIP registry. Of these, 12,929 were from

F

189
TH E JO U R NA L O F B O N E & JO I N T SU RG E RY J B J S . O RG
V O LU M E 97-A N U M B E R 3 F E B R UA RY 4, 2 015
d

d

d

EFFECTS OF REGIONAL VERSUS GENERAL ANESTHESIA
A F T E R T O TA L H I P A R T H R O P L A S T Y

ON

OUTCOMES

TABLE I Characteristics of Patients Receiving Regional or General Anesthesia
Before Propensity Score Matching
Regional*
(N = 5103 [39.5%])

General* (N = 7826
[60.5%]) (no. [%])

Primary

4583 (89.8)

6331 (80.9)

Revision

520 (10.2)

1495 (19.1)

1674 (32.8)

2807 (35.9)

ACS NSQIP-Speciﬁed Factors
Type of total hip replacement

P Value

P Value After
Matching

0.001

0.85

0.001

0.28

0.086

0.61

0.001

0.31

0.001

0.81

0.560

0.58

0.041

0.16

0.48

Demographic characteristics
Age
£60 yr
61-70 yr

1545 (30.3)

2289 (29.2)

>70 yr

1884 (36.9)

2730 (34.9)

Female

2865 (56.1)

4273 (54.6)

Male

2238 (43.9)

3553 (45.4)

White

3916 (76.7)

6527 (83.4)

Other

1187 (23.3)

1299 (16.6)

<30 kg/m2

3042 (59.6)

4425 (56.5)

30-40 kg/m2

1756 (34.4)

2806 (35.9)

Sex

Race/ethnicity

Preoperative health and comorbidities
Body mass index

>40 kg/m2
Hypertension (on medication)

305 (6)

595 (7.6)

2990 (58.6)

4627 (59.1)

Type II

471 (9.2)

696 (8.9)

Type I

126 (2.5)

252 (3.2)

240 (4.7)

361 (4.6)

0.832

8 (0.2)

32 (0.4)

0.016

0.80

28 (0.5)

55 (0.7)

0.312

0.89

798 (10.2)

0.023

0.56

80 (1.0)

0.027

0.71

461 (5.9)

0.034

0.75

34 (0.4)

0.004

1.0

325 (4.2)

0.001

0.60

108 (1.4)

0.001

0.72

340 (4.3)

0.001

0.89

40 (0.5)

0.036

1.0

Diabetes mellitus

Chronic obstructive pulmonary disease
Congestive heart failure symptoms within 1 mo
Myocardial infarction within 6 mo or angina within 1 mo
Revascularization (angioplasty or coronary artery bypass graft)
Peripheral vascular disease
History of stroke or transient ischemic attack
Dialysis
Steroid use
Systemic inﬂammatory response syndrome or sepsis preoperatively
Bleeding disorder
Transfusion: >4 units in 72 hr before surgery

458 (9)
33 (0.6)
256 (5)
7 (0.1)
154 (3)
33 (0.6)
100 (2)
13 (0.3)

Disseminated cancer

19 (0.4)

47 (0.6)

0.080

0.65

Chemotherapy or radiation therapy

18 (0.4)

29 (0.4)

0.996

0.87

0.001

0.69

1 or 2

2971 (58.2)

4058 (51.9)

3 or 4

2131 (41.8)

3768 (48.1)

ASA classiﬁcation†

Contaminated surgical site

331 (4.2)

0.046

0.82

19 (0.4)

49 (0.6)

0.063

0.40

Functional status: dependent

427 (8.4)

630 (8.1)

0.533

0.89

Dyspnea on exertion or at rest

355 (7.0)

616 (7.9)

0.056

0.73

>10% loss of body weight in last 6 mo

254 (5)

*The values are given as the number of patients with the percentage in parentheses. †One of the 5103 cases was not matched (used in the analysis).
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TABLE II Unadjusted Outcomes of Regional Versus General Anesthesia Before and After Propensity Score Matching
Before Propensity Score Matching
General*
(N = 7826)

11 (0.2)

61 (0.8)

3.19 ± 1.61

3.37 ± 1.62

256 (5.0)

556 (7.1)

0.7 (0.6-0.8);
p < 0.001

Mortality

15 (0.3)

39 (0.5)

0.59 (0.3-1.1)

15 (0.29)

20.1 (0.37)

0.78 (0.4-1.4)

Cardiovascular complications

44 (0.9)

121 (1.5)

0.55 (0.4-0.8);
p < 0.001

44 (0.86)

75.6 (1.40)

0.61 (0.4-0.9);
p < 0.01

Respiratory complications

23 (0.5)

85 (1.1)

0.41 (0.3-0.7);
p < 0.001

23 (0.45)

47.1 (0.87)

0.51 (0.3-0.8);
p < 0.01

Outcomes
Deep surgical site infection
Hospital length of stay (days)
Prolonged hospital length of stay§

OR (95% CI);
P Value

After Propensity Score Matching

Regional*
(N = 5103)

0.27 (0.1-0.5);
p < 0.001
0.95† (0.93-0.96);
p < 0.001

Regional*
(N = 5102)
11 (0.22)
3.19 ± 1.61
256 (5)

General*
(N = 5396)
30.6 (0.57)

OR (95% CI);
P Value
0.38 (0.2-0.7);
p < 0.01

3.35 ± 1.62

0.95‡ (0.93-0.97);
p < 0.001

354 (6.6)

0·75 (0.64-0.89);
p < 0.01

*The values are given as the number of patients with the percentage in parentheses, except for the hospital length of stay, which is given as the geometric
mean and standard deviation in days. †Geometric mean ratio = 6% (95% CI = 4% to 8%). ‡Geometric mean ratio = 5% (95% CI = 3% to 7%). §Prolonged
hospital length of stay is deﬁned as longer than the average plus two standard deviations (seven days or longer).

classic programs with no missing perioperative variables of interest (Fig. 1). There were 10,914 primary hip arthroplasties
(84.4%) and 2015 revision procedures (15.6%). Regional anesthesia was used for 5103 (39.5%) of the procedures, and general
anesthesia was used for 7826 (60.5%). The regional anesthesia
was spinal in 4377 (85.8%) of the cases, epidural in 126 (2.5%),
and “unspeciﬁed regional” in the remaining 600 (11.8%). The
rate of regional anesthesia in the non-classic programs was 39.1%,
and the rate of general anesthesia was 60.9%.
Before propensity score matching, sixteen of the twentyﬁve baseline factors differed signiﬁcantly between the two anesthesia groups. There were no signiﬁcant differences between
the groups after 1:2 matching and use of a caliper of 0.05 (Table
I). All regional anesthesia cases except one (5102 cases) were
matched to 5396 general anesthesia cases.
Deep surgical site infections were signiﬁcantly less
common after regional anesthesia than after general anesthesia
(0.22% compared with 0.57%), with an odds ratio (after
matching) of 0.38 (95% conﬁdence interval [CI] = 0.20 to 0.72;
p < 0.01). Deep surgical site infections were also associated
with revision arthroplasties, age, and insulin-dependent diabetes (Tables II and III).
The unadjusted average hospital length of stay, after
matching, was shorter after regional anesthesia (geometric mean
and SD, 3.2 ± 1.6 days) than after general anesthesia (geometric
mean, 3.4 ± 1.6 days). Proportionally, this yields an odds ratio
(OR) for length of stay of 0.95 (95% CI = 0.93 to 0.97) for regional
anesthesia with a mean difference (compared with general anesthesia) of 0.05 (95% CI = 0.03 to 0.07; p < 0.001), which translates
to 0.17 day for each total hip arthroplasty (Table II).
The adjusted odds of the hospital length of stay were 8%
lower in the regional anesthesia group (OR = 0.92; 95% CI =
0.89 to 0.94; p < 0.001) (see Appendix). Figure 2 shows consistent earlier discharge (shorter hospital length of stay) in the

regional anesthesia group compared with the general anesthesia group. The odds of a patient having a prolonged hospital
length of stay, after we controlled for other factors, was 24%
lower in the regional anesthesia group: 5% compared with
6.6% in the general anesthesia group (OR = 0.73; 95% CI =
0.68 to 0.89; p < 0.001).
Thirty-day mortality was a rare event, with an aftermatching prevalence of 0.29% in the regional anesthesia group
and 0.37% in the general anesthesia group (Table II). In the
multivariable analysis, the mortality odds were not signiﬁcantly
lower in the regional anesthesia group (OR = 0.78; 95% CI = 0.43

Fig. 2

Kaplan-Meier survival curves showing adjusted cumulative hazard of
hospital discharge comparing regional anesthesia to general anesthesia.
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TABLE III Results of Multivariable Logistic Regression Analyses for Deep Surgical Site Infection, Mortality, and Respiratory Complications
OR (95% CI); P Value
Factor

Deep Surgical Site Infection

Mortality

Respiratory Complications

Regional anesthesia

0.38 (0.2-0.7); p < 0.01

0.78 (0.4-1.4)

0.51 (0.3-0.8); p < 0.01

Revision total hip arthroplasty

3.11 (1.8-5.3); p < 0.001

2.24 (1.1-4.5); p < 0.05

1.94 (1.2-3.1); p < 0.01

Age
£60 yr
61-70 yr
>70 yr
ASA class 3 or 4
Diabetes mellitus
No

Reference

Reference

Reference

3.40 (1.7-6.8); p < 0.01

1.07 (0.3-4.3)

2.29 (1.2-4.6); p < 0.01

5.94 (2.1-17.1); p < 0.01

3.34 (1.8-6.1); p < 0.001

1.33 (0.8-2.3)

2.24 (1.2-4.4); p < 0.05

4.68 (2.4-7.7); p < 0.001

Reference

Reference

1.66 (0.8-3.3)

Reference

Non-insulin dependent

0.76 (0.3-2.1)

0.51 (0.1-2.1)

0.93 (0.5-1.8)

Insulin-dependent

3.27 (1.4-7.9); p < 0.05

3.10 (1.1-9.0); p < 0.05

4.27 (2.4-7.7); p < 0.001

to 1.42; p > 0.05) (Fig. 3). Factors that were signiﬁcantly associated with increased postoperative mortality were revision total
hip arthroplasty (OR = 2.24; 95% CI = 1.12 to 4.48; p < 0.05), an
age of more than seventy years compared with an age of less than
ﬁfty years (OR = 5.94; 95% CI = 2.06 to 17.1; p < 0.01), ASA class

3 or 4 compared with ASA class 1 or 2 (OR = 2.24; 95% CI = 1.15
to 4.36; p < 0.05), and insulin-dependent diabetes compared with
no diabetes (OR = 3.10; 95% CI = 1.1 to 9.02; p < 0.05).
The adjusted odds for cardiovascular complications (OR =
0.61; 95% CI = 0.44 to 0.85) and respiratory complications

Fig. 3

Logistic regression analysis result for outcomes comparing regional anesthesia with general anesthesia after propensity score matching. The diamonds
indicate the odds ratios, which show a decreased odds for each outcome with regional anesthesia, and the lines through the diamonds indicate the 95% CI.
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(OR = 0.51; 95% CI = 0.33 to 0.81) were all lower with regional
anesthesia (Fig. 3).
Other important factors affecting the outcomes are summarized in Table III and a table in the Appendix.
Discussion
sing the ACS NSQIP database and a propensity-matched
analysis, we studied the impact of anesthesia type on thirtyday outcomes following total hip arthroplasty. Compared with
general anesthesia, regional anesthesia was associated with impressive reductions in postoperative deep surgical site infection
rates, hospital length of stay, and rates of cardiovascular and
pulmonary complications. Regional anesthesia was associated
with a nonsigniﬁcant 0.2% decrease in mortality. As mortality in
the thirty days following total hip arthroplasty is rare, and the
possible decrease in mortality attributable to regional anesthesia
is low, a very large study would be needed in order to detect a
mortality beneﬁt attributable to regional anesthesia.
The severity of comorbidities as well as the duration of
surgery, the length of the preoperative hospital stay, and low
hospital volume have been identiﬁed as risk factors for deep
surgical site infection following total hip replacement27. Preventive measures such as timely administration of antibiotics,
maintenance of normothermia, and minimizing transfusions
are well known28, but previous reports did not show regional
anesthesia to have as important an effect on deep surgical site
infections after total hip or knee replacement29,30. Possible
mechanisms for how regional anesthesia lowers the prevalence
of deep surgical site infection might be alterations in immune
response31 and sympathetic blocking effects with concomitant
vasodilation improving tissue perfusion and oxygenation32.
Hospital length of stay is often used as a proxy for postoperative complications and resource utilization33. The study of
prolonged hospital stay or length-of-stay outliers is essential for
the management and ﬁnancing of hospitals. We chose to deﬁne
a prolonged length of stay as the geometric mean plus two
standard deviations as this approach was superior to three
others in predicting cost34. Regional anesthesia was associated
with decreases in all measures related to length of stay. Given
that total hip arthroplasty is such a common surgical procedure,
even a minor decrease in hospital length of stay could have major
resource-savings implications.
Previous studies comparing regional anesthesia and general anesthesia have demonstrated conﬂicting results. Some
studies have not shown beneﬁts9,10, while others have demonstrated decreased blood loss, fewer respiratory complications,
and a lower risk of thromboembolism with regional anesthesia11,35,36. In a recent retrospective analysis from the National Joint
Registry for England and Wales of ninety-day mortality after
total hip replacement, spinal anesthesia, but not epidural anesthesia, was associated with a lower mortality rate5. The limitations of some of these studies as guides for current standards of
care include relatively low patient numbers and changes in
perioperative practice since the collection of the data. Memtsoudis and colleagues reported similar results concerning pulmonary, cardiac, and infectious complications in a large data set
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of patients who underwent total hip or knee arthroplasty under
regional or general anesthesia 37. That study had potential
limitations; the database was administrative rather than
medical, 27% of the cases had missing data on anesthesia type,
a high percentage of patients received combined regional and
general anesthesia, and the reported complication rates were
in-hospital.
The credibility and general applicability of the main
ﬁndings of our study are supported by several factors. First, the
results are based on a recent, prospectively collected, multicenter data set of patients who underwent primary or revision
total hip arthroplasty at a wide range of hospitals in both
the private and the academic sector. Second, we utilized a
propensity-score-matching technique in an attempt to balance
factors affecting the exposure and regression models to control for confounders affecting the outcome. Third, the estimated prevalences of each of the individual complications
included in the composite outcomes were consistently lower
for patients who received regional anesthesia, suggesting beneﬁt across complications. Fourth, the results are biologically
plausible, as regional techniques and drugs block sympathetic
nerve activity, reduce cytokine production, and inhibit platelet
function7,8.
This study has important limitations. As it was not a
randomized controlled trial, despite statistical corrections,
unaccounted (unobserved) factors could have biased treatment exposure (to regional or general anesthesia), and hidden
confounders might have biased the outcomes. For example,
there could have been location bias, as the proportion of each
anesthetic type might differ according to hospital center.
Quality of care in general is likely to vary among hospital
centers as well.
Another important limitation is that details about the
general anesthetics were not considered. The outcomes associated with general anesthesia with long-acting agents, inadequate
analgesia, hemodynamic shifts, and unnecessarily deep anesthesia might be very different from those associated with
“fast-track” general anesthesia with rapid and predictable
agents, multimodal analgesia, targeted hemodynamic control,
and appropriately titrated anesthetic depth. These aspects and
other unrecorded perioperative information (for example,
postoperative pain and delirium) could have biased the
outcomes.
In conclusion, although the ACS NSQIP utilizes a systematic sampling approach that is not guaranteed to provide
a perfect estimate of procedure-type prevalence across the
country, if the data observed here are reﬂective, then despite
emerging evidence regional anesthesia appears to have been
potentially underutilized during this study period (used for
only 40% of total hip arthroplasties). The results reported here
add credence to the notion that regional anesthesia is associated
with a reduction in deep surgical site infection rates, length of
hospital stay, and postoperative morbidity compared with
general anesthesia. These ﬁndings, if replicated in appropriately
designed effectiveness studies, could have an important medical and economic impact on health-care practice.
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Appendix
A table showing the results of multivariable logistic regression analyses for hospital length of stay and cardiovascular complications is available with the online version of
this article as a data supplement at jbjs.org. n
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